Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.

Air pollution is a well-known risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).

Parts of the model represent different parts of the respiratory system as shown here. The model, which is air tight, represents the thorax, and air is only able to enter via the glass tube which ...

Trusted source of information on Respiratory Disorders that includes articles, news, videos, animations, quizzes, calculators and drugs.

After entering the body, the virus attaches to the epithelial cells lining the respiratory tract, which includes airways and the lungs. These epithelial cells form a protective barrier in the airways, ...

For many, infection causes mild upper respiratory tract illness that resembles the common cold, but in up to 40% of infected children the disease progresses to an LRTI such as bronchiolitis or ...

appstate.edu Objective Limited data imply an inverse relationship between physical activity or fitness level and the rates of upper respiratory tract infection (URTI). The purpose of this study was to ...

By making informed food choices and adopting a healthy lifestyle, you can effectively support your respiratory system and reduce the risk of respiratory illnesses, thereby promoting overall well ...

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.